Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CreaNutrition was a Swiss-based life sciences company that specialized in the development and marketing of functional food ingredients, most notably the OatWell brand of oat beta-glucan. The company focused on clinically proven ingredients that address major health concerns such as high cholesterol and blood sugar management. Its products were supported by extensive clinical research and achieved significant regulatory milestones, including health claim approvals from the EFSA and the FDA. In 2013, the OatWell business and associated assets were acquired by DSM Nutritional Products, integrating CreaNutrition's portfolio into DSM's global nutrition division. Today, the technology remains a leading solution in the heart health and metabolic wellness sectors under the dsm-firmenich umbrella.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CreaNutrition.